Andrés Cervantes

Professor of Medicine

University of Valencia

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Cristina Estornut Navarro

Professor

Universidad Europea de Valencia SLU

SPAIN

View details

Tenna Henriksen

Aarhus University

DENMARK

View details

Elena Jiménez-Martí

Profresora Ayudante Doctor

University of Valencia

SPAIN

View details

Amanda Frydendahl

Aarhus University

DENMARK

View details

Matteo Frasson

SPAIN

View details

Isabel Castro

Professor

University of Valencia

SPAIN

View details

Uffe Schou Løve

Aarhus University

DENMARK

View details

José Martínez-Lillo

University of Valencia

SPAIN

View details

MARTIN PEREZ-LEAL

Professor

Universidad Europea de Valencia SLU

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrés Cervantes

Research Interests

Explore related searches

Contact this professor

Articles (10)

In the literature: July 2023

The percentage of mesorectal infiltration as a prognostic factor after curative surgery for pT3 rectal cancer

Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences

RUNAT-BI: A Ruthenium(III) Complex as a Selective Anti-Tumor Drug Candidate against Highly Aggressive Cancer Cell Lines

Will Organoids Fill the Gap towards Functional Precision Medicine?

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients

Clinical management of metastatic colorectal cancer in the era of precision medicine

Colorectal cancer survival: prevalence of psychosocial distress and unmet supportive care needs

Corrigendum: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: (Annals of Oncology (2018) 29(S4) (iv238–iv255), (S0923753419317119), (10.1093/annonc/mdy308))

First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma

Collaborators (9)

Cristina Estornut Navarro

Tenna Henriksen

Elena Jiménez-Martí

Amanda Frydendahl

Matteo Frasson

Isabel Castro

Uffe Schou Løve

José Martínez-Lillo

MARTIN PEREZ-LEAL

Make your next move.